Path

Measles

Rubella

Current expected 

Achieve 95% reduced mortality by 2020 and existing national and regional goals 5 years later than target date then maintain

Introduce at least one dose in 75% or more of countries yet to introduce RCV by 2020 and achieve existing national and regional goals 5 years later than target date

Achieve existing goals on time

Achieve 95% reduced mortality by 2015 and existing national and regional goals (eliminate in 4 regions by 2015, 5 regions by 2020)

Introduce at least one dose in 75% or more of countries yet to introduce RCV by 2018 and achieve existing national and regional goals (eliminate in 2 regions by 2015)

Achieve GVAP goals [46]

Achieve 95% reduced mortality and elimination in at least four WHO regions by 2015, and eliminate measles in at least 5 WHO regions by 2020 then maintain

Eliminate rubella in at least two WHO regions by 2015 and in at least 5 WHO regions by 2020 then maintain

Accelerated eradication

Achieve 95% reduced mortality by 2015 and eradication by 2020 then maintain

Eradicate rubella by 2020 then maintain

Delayed eradication

Achieve 95% reduced mortality by 2020 and eradication by 2030 then maintain

Eradicate rubella by 2035 then maintain

Eradicate through routine immunization

Achieve 95% reduced mortality by 2030 and eradication by 2040 then maintain

Eradicate rubella by 2040 then maintain

Control

Coordinated control associated with continued use of MCVs in all countries

Uncoordinated control associated with one or more countries not choosing to use a RCV

Uncoordinated

Uncoordinated control associated with continued use of MCVs in all countries

Uncoordinated control associated with one or more countries not choosing to use a RCV

Table 1: Range of minimum global immunization options for measles and rubella.